Kannalife
Doylestown
About Kannalife
Kannalife, a subsidiary of Neuropathix, Inc (OTCQB: NPTX), is a biopharmaceutical company focused on discovering, developing, and commercializing a product platform of novel molecules from our proprietary next-generation cannabinoid therapeutics as potent, non-opioid alternatives to treat patients with a variety of unmet medical needs.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: Less than $1M
- Total funding: $6.0M
- Last round: Grant (Jun 2024)
- Website: kannalife.com
- Phone: (215) 695-6559
Industries & Categories
Biotechnology, Health Care, Pharmaceutical
Social Profiles
Canonical: https://fsome.com/organization/kannalife-19243 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.